Company Search:
Advanced Search
Sponsored Links
Oncodesign Sa Company Snapshot
Oncodesign Sa operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oncodesign Sa with three other companies in this sector in France: Cellectis SA (2018 sales of 18.19 million Euro [US$20.12 million] of which 98% was Therapeutics), Ose Immunotherapeutics SA (24.46 million Euro [US$27.05 million] ), and Eurofins-Cerep SA (25.45 million Euro [US$28.16 million] ).

Sales Analysis. During the year ended December of 2018, sales at Oncodesign Sa were 20.09 million Euro (US$22.22 million). This is an increase of 40.4% versus 2017, when the company's sales were 14.31 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Oncodesign Sa
  Stock Performance Chart for Oncodesign Sa
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 6.02
(Figures in Euro)
1 Week 0.7%   13 Weeks -7.1%  
4 Weeks -24.9%   52 Weeks -18.0%  
Oncodesign Sa Key Data:
  Ticker: ALONC Country: France
  Exchanges: PAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 20,087,000
(Year Ending Jan 2019).
Employees: 229
  Currency: Euro Market Cap: 40,942,411
  Fiscal Yr Ends: December Shares Outstanding: 6,801,065
  Share Type: Ordinary Closely Held Shares: 3,477,390
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.